![Andrew McKibben](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew McKibben
Contatto Relazioni con gli Investitori presso MIRUM PHARMACEUTICALS, INC.
Provenienza dei contatti di primo grado di Andrew McKibben
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 19 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Andrew McKibben tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | General Counsel Chief Operating Officer Corporate Officer/Principal Director/Board Member | |
SillaJen Biotherapeutics, Inc.
![]() SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal | |
Flashlight Therapeutics, Inc.
![]() Flashlight Therapeutics, Inc. BiotechnologyHealth Technology Flashlight Therapeutics, Inc. develops therapeutics for unmet medical needs. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
Frazier Management LLC
![]() Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Masters Business Admin | |
RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
University of Geneva | College/University | Doctorate Degree | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Red Rock Capital Management, Inc. | Corporate Officer/Principal | ||
DuPont Pharmaceuticals Co.
![]() DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cervantes Life Science Partners LLC | Corporate Officer/Principal | ||
Council on International Educational Exchange, Inc.
![]() Council on International Educational Exchange, Inc. Miscellaneous Commercial ServicesCommercial Services Council on International Educational Exchange, Inc. provides educational services. The firm is a non-profit study abroad and intercultural exchange organization, transforms lives and builds bridges by promoting the exchange of ideas and experiences. It offers opportunities for cultural exchange, including work exchange programs, teach abroad programs, and a worldwide portfolio of study abroad and internship programs for college and high school students. The company was founded in 1947 and is headquartered in Portland, ME. | Miscellaneous Commercial Services | Chairman | |
HLS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
EDGEWISE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Pacira Pharmaceuticals, Inc. (California)
![]() Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
T-Knife Therapeutics, Inc. | Director/Board Member | ||
California Life Sciences Association
![]() California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
ALZA CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
PANACOS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
University of California, Berkeley | College/University | Undergraduate Degree | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
PathoGenesis Corp
![]() PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Biotechnology | Chief Tech/Sci/R&D Officer | |
EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Stanford University School of Medicine | College/University | Doctorate Degree | |
INTERMUNE INC | Biotechnology | Corporate Officer/Principal | |
Harvard Medical School | College/University | Graduate Degree | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member | |
ARATANA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Ohio University Foundation | Director/Board Member | ||
The Ohio University
![]() The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | College/University | Undergraduate Degree | |
Vytal, Inc.
![]() Vytal, Inc. Drugstore ChainsRetail Trade Vytal, Inc. provides medication access, adherence, and direct-to-patient consumer programs. It offers prescription assistance, patient engagement, anticipatory logistic solutions, and omni-channel platform. The company was founded Levin Scott Bechtler, Paul Cattaneo, and Robert J. Feeney Jr. in 2000 and is headquartered in San Diego, CA. | Drugstore Chains | Corporate Officer/Principal | |
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Chairman | |
Senti Sub I, Inc.
![]() Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 48 |
Irlanda | 2 |
Svizzera | 2 |
Canada | 2 |
Settori
Health Technology | 33 |
Consumer Services | 9 |
Commercial Services | 4 |
Finance | 2 |
Technology Services | 2 |
Posizioni
Director/Board Member | 148 |
Independent Dir/Board Member | 65 |
Corporate Officer/Principal | 56 |
President | 28 |
Chief Executive Officer | 25 |
Contatti più connessi
Insiders | |
---|---|
Patrick Heron | 42 |
Timothy Walbert | 40 |
Michael Grey | 32 |
Laura Brege | 27 |
Laurent Fischer | 23 |
Eric Bjerkholt | 21 |
Sona Saira Ramasastry | 19 |
William Fairey | 15 |
Lon Cardon | 13 |
Pamela Vig | 12 |
Joanne Quan | 12 |
Christopher Peetz | 11 |
Paul K. Ross | 8 |
Peter Radovich | 7 |
Lara Krupka-Longpre | 7 |
- Borsa valori
- Insiders
- Andrew McKibben
- Connessioni Società